*Please click here to view the programme at a glance in PDF.
SEPTEMBER 6, 2022 - TUESDAY | |||
Time Slot | PLENARY HALL "EXCHANGE AUDITORIUM" |
PARALLEL HALL "EXCHANGE ROOM 9" |
OTHER HALLS |
10:00 – 17:00 |
|
ESCV PRE-CONFERENCE WORKSHOP: For further details regarding the programme and registering for the pre-conference workshop, please click HERE. |
SEPTEMBER 7, 2022 - WEDNESDAY | ||||
Time Slot | PLENARY HALL "EXCHANGE AUDITORIUM" |
PARALLEL HALL "EXCHANGE ROOM 9" |
OTHER HALLS | |
13:30 – 15:00 |
SESSION 1: Neurological Infections Offered Talks: OP-002 Rift valley fever virus infects the sensory nervous system of zebrafish larvae in a JAK/STAT-dependent manner OP-003 Catastrophic bilateral sudden sensorineural hearing loss following COVID-19 |
|||
15:00 – 16:00 |
SESSION 2: Emerging and Re-emerging Viral Diseases Chairs: Marcus Panning, Germany & Heli Harvala, UK Offered Talks: OP-005 Dengue serotype and co-infection association with dengue severity during 2021 in Jodhpur, Rajasthan, India OP-006 Metagenomics virome analysis of {Culex} spp. in northern Greece |
|||
16:00 – 16:30 | COFFEE BREAK | |||
16:30 – 17:30 |
SESSION 3 OPENING KEYNOTE: Keynote Lecture: |
|||
17:30 – 18:00 |
TWiV with Vincent Racaniello Vincent Racaniello, USA with Richard Knight, UK |
|||
18:00 – 20:00 |
WELCOME RECEPTION |
SEPTEMBER 8, 2022 - THURSDAY | ||||
Time Slot | PLENARY HALL "EXCHANGE AUDITORIUM" |
PARALLEL HALL "EXCHANGE ROOM 9" |
OTHER HALLS | |
08:00 – 09:00 |
Industry Symposium 1 |
|||
09:00 – 10:30 |
SESSION 4: SARS-CoV-2 Chairs: Catherine Moore, UK & Susannah Froude,UK Offered Talks: OP-008 The diagnostic potential of activated CD8+ T-cells during acute COVID-19 OP-009 Transplacental transmission of anti-SARS-CoV-2 neutralizing antibodies in comparison to other micro-organisms (CompaCoV) OP-010 Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants |
|||
10:30 – 11:00 | COFFEE BREAK | |||
11:00 – 12:30 |
SESSION 5: Vaccines/Vaccinology Chairs: Javier Buesa, Spain & Pamela Vallely, UK Offered Talks: OP-013 Spray-freeze-dried mixed MS2-L2 VLPs: a thermostable candidate HPV vaccine that is applicable in low and middle-income countries OP-014 Two-component Vaccine Consisting of Virus-Like Particles Displaying Hepatitis C Virus Envelope Protein 2 Oligomers OP-015 Sex and age as determinants of antibody kinetics elicited by BNT162b2 (Pfizer-BioNTech) vaccine against SARS-CoV-2 |
|||
12:30 – 14:00 | LUNCH BREAK (Council Meeting will be held during the lunch break) |
|||
12:30 - 13:30 |
Hall: Exchange Room 11 Vincent Racaniello, USA with Emma Thomson, UK |
|||
13:00 - 14:00 | Industry Symposium 2 Please check the symposium details from the Industry Symposia section |
Industry Symposium 3 Please check the symposium details from the Industry Symposia section |
13:00 - 13:45 | Exchange Room 10 ESCV Network on NGS (ENNGS): Past, Current, and Future Activities Organised by: Xavier Lopez-Labrador, Spain & Jutte de Vries, Netherlands |
|
14:00 – 15:30 |
SESSION 6: Respiratory Viruses Chairs: Kate Templeton, UK & Joel Paul, UK Offered Talks: OP-018 Impact of detection of respiratory pathogens by a rapid multiplex PCR assay on the management of Community-Acquired Pneumonia for children at the Paediatric emergency department. OP-019 Nasopharyngeal excretion dynamics of SARS-CoV-2 in unvaccinated asymptomatic and mildly symptomatic patients OP-020 Paper-based sensors for SARS-CoV-2 detection for early warning of pandemic |
|||
15:30 – 16:00 | COFFEE BREAK | |||
16:00 – 17:30 |
SESSION 7: NGS and Virus Discovery Chairs: Peter Coyle, Qatar & Esther Babady Otete, USA Offered Talks: OP-023 The donor lung is a major contributor to human cytomegalovirus strain diversity and dynamics after transplantation OP-024 Detection of cardiotropic viruses in endomyocardial biopsies of patients with unexplained heart failure via targeted next generation sequencing OP-025 Metagenomic sequencing with spiked primer enrichment (MSSPE) for genotype-independent Hepatitis C virus (HCV) whole-genome analysis and antiviral resistance testing OP-026 Genotyping and variant calling of human adenoviruses by tiled amplicon sequencing |
|||
17:30 – 19:30 | POSTER SESSION 1 Location: Posters' Area "Exchange Hall" Poster presenters are requested to be at the Posters’ Area for any possible discussions to be done about their posters. |
SEPTEMBER 9, 2022 - FRIDAY | ||||
Time Slot | PLENARY HALL "EXCHANGE AUDITORIUM" |
PARALLEL HALL "EXCHANGE ROOM 9" |
OTHER HALLS | |
08:00 – 09:00 | Industry Symposium 4 Please check the symposium details from the Industry Symposia section |
|||
09:00 – 10:30 |
SESSION 8: Viral Hepatitis Chairs: William Irving, UK & Paul Klapper, UK Keynote Lecture: Offered Talks: OP-028 Microarray analysis of virus-specific IgM and IgG antibodies significantly improves the serological diagnosis of Hepatitis E Virus infection OP-029 Host Genetic Variants Associated with Hepatitis E Virus: A Genome-Wide Association Study in Qatar OP-030 Prevalence of musculoskeletal manifestations among patients with hepatitis C virus infection |
|||
10:30 – 11:00 | COFFEE BREAK | |||
11:00 – 12:30 |
SESSION 9: Immune Response to Infection Chairs: George Sourvinos, Greece & Paulo Paixao, Portugal
OP-032 Elevated levels of CXCL16 in severe COVID-19 patients: effects on mortality OP-033 Role of the Chromosome 19 microRNA Cluster During Viral Congenital Infections OP-034 Absence of rapid T cell control corresponds with delayed viral clearance in hospitalised COVID-19 patients OP-035 Pichinde virus infection of mice and guinea pigs as comparative animal models for human Lassa fever: Immunity, immune evasion, and disease pathogenesis |
|||
12:30 – 14:00 | LUNCH BREAK & POSTER SESSION 2 Location: Posters' Area "Exchange Hall" Poster presenters are requested to be at the Posters’ Area for any possible discussions to be done about their posters. |
|||
13:00 - 14:00 Industry Symposium 5 Please check the symposium details from the Industry Symposia section |
13:00 - 14:00 Industry Symposium 6 Please check the symposium details from the Industry Symposia section |
|||
14:00 – 15:30 |
SESSION 10: Late Breakers Chairs: Bert Niesters, Netherlands & George Sourvinos, Greece Offered Talks: OP-037 High prevalence of cutavirus in parapsoriasis patients OP-039 Role of Long Non-Coding RNAs (lncRNAs) in HIV Latency OP-040 Severe Influenza during the 2020-21 and 2021-22 SARS-CoV-2 pandemic seasons. Re-appearance of severe H3N2 cases in 2022 |
|||
15:30 – 16:00 | COFFEE BREAK | |||
16:00 – 17:30 |
SESSION 11: Clinical Cases Chairs: Heli Harvala, UK & William Irving, UK
Offered Talks: OP-041 Congenital Cytomegalovirus Infection Among Twins: Lessons Learnt from Two Cases and Implications for Screening OP-042 Two investigations into severe non A-E hepatitis in young children in the UK OP-043 Suspected Hantavirus in Africa: nephrotic syndrome in a traveller returning from Democratic Republic of Congo OP-044 Orf’ally Swollen |
|||
17:30 – 18:00 | ESCV GENERAL ASSEMBLY (With the attendance of ESCV members) |
|||
19:30 - |
CONFERENCE NETWORKING DINNER |
SEPTEMBER 10, 2022 - SATURDAY | ||||
Time Slot | PLENARY HALL "EXCHANGE AUDITORIUM" |
PARALLEL HALL "EXCHANGE ROOM 9" |
OTHER HALLS | |
09:00 – 10:30 |
SESSION 12: Antivirals
“Lecture to be followed by presentation of the Gardner Award to Johan Neyts, Belgium” Offered Talks: OP-047 Surveillance of herpes simplex virus and varicella-zoster virus resistance to antivirals over a 14-year period OP-048 The effect of introducing Letermovir as prophylaxis for haematopoetic stem cell transplants on morbidity and mortality in Birmingham, UK |
|||
10:30 – 11:00 | COFFEE BREAK | |||
11:00 – 12:00 |
SESSION 13: Panel discussion – Is less more? Christopher Smith, UK, The Naked Virologist |
|||
12:00 – 13:00 |
|